{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:12:36Z","timestamp":1789517556196,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009933","name":"Johnson & Johnson MedTech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009933","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020297","name":"Abiomed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hlc.2026.01.019","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:23:35Z","timestamp":1780658615000},"page":"1313-1320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-Effectiveness of Impella Versus Veno-Arterial Extracorporeal Membrane Oxygenation in Patients With Acute Myocardial Infarction Cardiogenic Shock"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-3185","authenticated-orcid":false,"given":"Riley","family":"Batchelor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1512-4255","authenticated-orcid":false,"given":"Jocasta","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8112-504X","authenticated-orcid":false,"given":"Steven","family":"Theng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sierakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6455-6777","authenticated-orcid":false,"given":"Mia","family":"Mudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahlia","family":"Seage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9611-7120","authenticated-orcid":false,"given":"Stelios I.","family":"Tsintzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Stub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2026.01.019_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018","volume":"27","author":"Atherton","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.019_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.028","article-title":"The International Society for Heart and Lung Transplantation\/Heart Failure Society of America guideline on acute mechanical circulatory support","volume":"42","author":"Bernhardt","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2026.01.019_bib3","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.01.019_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-2003-45422","article-title":"Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock","volume":"51","author":"Meyns","year":"2003","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.hlc.2026.01.019_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.004905","article-title":"Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest","volume":"11","author":"Rao","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hlc.2026.01.019_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.carrev.2017.12.016","article-title":"Insertion of the Impella via the axillary artery for high-risk percutaneous coronary intervention","volume":"19","author":"Truong","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib7","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.3390\/jcm12175576","article-title":"Extracorporeal membrane oxygenation (VA-ECMO) in management of cardiogenic shock","volume":"12","author":"Koziol","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.xjtc.2022.02.039","article-title":"Extracorporeal membrane oxygenation and left ventricular unloading: what is the evidence?","volume":"13","author":"Lorusso","year":"2022","journal-title":"JTCVS Tech"},{"key":"10.1016\/j.hlc.2026.01.019_bib9","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.3390\/jcm11143955","article-title":"Impella versus venoarterial extracorporeal membrane oxygenation for acute myocardial infarction cardiogenic shock: a systematic review and meta-analysis","volume":"11","author":"Batchelor","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib10","first-page":"203","article-title":"Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study","volume":"13","author":"Beer","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.hlc.2026.01.019_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.amjcard.2020.10.056","article-title":"Analysis of Adverse Events Related to Impella Usage (from the Manufacturer and User Facility Device Experience and National Inpatient Sample Databases)","volume":"140","author":"Philipson","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2026.01.019_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030819","article-title":"Complications and outcomes of Impella treatment in cardiogenic shock patients with and without acute myocardial infarction","volume":"12","author":"Saito","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2026.01.019_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.21037\/atm.2020.03.152","article-title":"Complications associated with mechanical circulatory support","volume":"8","author":"Ali","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib14","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","article-title":"Extracorporeal life support in infarct-related cardiogenic shock","volume":"389","author":"Thiele","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4244\/EIJ-D-23-00204","article-title":"Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised euro SHOCK trial","volume":"19","author":"Banning","year":"2023","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.hlc.2026.01.019_bib17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","article-title":"Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: results of the ECMO-CS randomized clinical trial","volume":"147","author":"Ostadal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.01.019_bib18","first-page":"658","article-title":"Do DanGer-SHOCK-like patients benefit from VA-ECMO treatment in infarct-related cardiogenic shock? results of an individual patient data meta-analysis","volume":"13","author":"Zeymer","year":"2024","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.hlc.2026.01.019_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.healun.2024.01.006","article-title":"Why VA-ECMO should not be used routinely in AMI-Cardiogenic Shock","volume":"43","author":"Thiele","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2026.01.019_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SHK.0000000000002540","article-title":"Impella compared to venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a systematic review and meta-analysis of propensity score-matched studies","volume":"63","author":"Stub","year":"2025","journal-title":"Shock"},{"key":"10.1016\/j.hlc.2026.01.019_bib21","first-page":"279","article-title":"Resource utilization associated with extracorporeal membrane oxygenation vs. microaxial flow pump for infarct-related cardiogenic shock","volume":"14","author":"Bogerd","year":"2025","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.hlc.2026.01.019_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13054-014-0516-y","article-title":"Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) Registry","volume":"18","author":"Aissaoui","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.hlc.2026.01.019_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00392-020-01777-9","article-title":"Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis","volume":"110","author":"Karatolios","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hlc.2026.01.019_bib24","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.3390\/jcm10163583","article-title":"Comparison of mechanical support with Impella or extracorporeal life support in post-cardiac arrest cardiogenic shock: a propensity scoring matching analysis","volume":"10","author":"Syntila","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2026.01.019_bib25","first-page":"329","article-title":"Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score","volume":"8","author":"Schiller","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.hlc.2026.01.019_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101047","article-title":"Resource utilization and costs associated with cardiogenic shock complicating myocardial infarction: A population-based cohort study","volume":"3","author":"Parlow","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.hlc.2026.01.019_bib28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/medicina57080747","article-title":"Quality of life following urgent LVAD implantation for ECMO therapy in cardiogenic shock: A long-term follow-up","volume":"57","author":"Berger","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.hlc.2026.01.019_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.18773\/austprescr.2017.014","article-title":"Economic evaluation of medicines","volume":"40","author":"Taylor","year":"2017","journal-title":"Aust Prescr"},{"key":"10.1016\/j.hlc.2026.01.019_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40119-025-00404-w","article-title":"Impella versus VA-ECMO for patients with cardiogenic shock: preliminary cost-effectiveness analysis in the Italian context","volume":"14","author":"Rognoni","year":"2025","journal-title":"Cardiol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.hlc.2026.01.019_bib31","article-title":"Outcomes and associated costs with temporary mechanical circulatory support devices in patients with cardiogenic shock","volume":"144","author":"Malik","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2026.01.019_bib32","first-page":"703","article-title":"Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: an episode-of-care analysis","volume":"98","author":"Vetrovec","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2026.01.019_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/CEOR.S278269","article-title":"Budget impact associated with the introduction of the Impella 5.0\u00ae mechanical circulatory support device for cardiogenic shock in France","volume":"13","author":"Le Guyader","year":"2021","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.hlc.2026.01.019_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.hlc.2025.06.003","article-title":"Riding the Impella wave in cardiogenic shock: is it time for Australia to get on board?","volume":"34","author":"Stub","year":"2025","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2026.01.019_bib36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJMc2508284","article-title":"Long-term outcomes of the DanGer shock trial","volume":"393","author":"M\u00f8ller","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950626001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:48:35Z","timestamp":1788900515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950626001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1443950626001915"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.019","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Impella Versus Veno-Arterial Extracorporeal Membrane Oxygenation in Patients With Acute Myocardial Infarction Cardiogenic Shock","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2026.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}